Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity.
about
Hematopoietic stem cell transplantation for MDS.Current therapy of myelodysplastic syndromesThere's risk, and then there's risk: The latest clinical prognostic risk stratification models in myelodysplastic syndromes.Current status of allogeneic hematopoietic cell transplantation for MDS.Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: the past decade.Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms.Long-term follow-up after allogeneic stem cell transplantation in patients with myelodysplastic syndromes or secondary acute myeloid leukemia: a single center experience.Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: current status.When to transplant MDS, and what to do when transplant fails.Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes.Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant.Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia.WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients.Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome.Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5 %-a feasibility study.Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome.
P2860
Q33767314-28AE0B32-6848-4417-B9F4-19F23B80DF9BQ34013796-E036639A-CE40-401F-85AF-0467FC7EA5D6Q34049017-690EA6D5-C4A6-4F1D-9A2D-9AACE1274ED2Q36063049-6259B94F-1897-4EF7-B62B-6C0228045555Q36811828-B8A9C564-9244-46C9-A0AE-1DBD50E4CB11Q37205584-F971E0BD-6A9A-4AA6-870B-EECBE8AAB2D9Q37730013-3FBDE7AB-A3FB-4DED-8B32-FD978DB4C934Q37955235-F40E83C9-0A81-4003-A4C5-D0DD7F2F9DECQ37964938-73C77BCA-F8D9-4F17-ACA4-8FC38D649539Q38148983-1BE54038-D64E-4E00-9FB3-33B62C594475Q38893877-2DF33768-C229-45A7-8CF1-D06827BF5AF2Q39805438-8D4BDD68-C6AD-4FD4-A220-BC69B7858440Q43451303-837C9A25-D42D-4B73-82B5-D364317B868BQ44066797-A0A3AEAA-9771-4631-B952-26CB4FF66056Q45756342-C10C93A8-DDC1-4438-903D-AB03F540FD5FQ48733699-4E3D49DF-F995-4C97-8A27-63D47393E51EQ53116636-E579CF1A-3CAC-4BC7-837E-48B88B786A81Q53429887-5AB8CCB1-D020-4652-A019-A6EFF8132CB1
P2860
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Allogeneic hematopoietic cell ...... nt IPSS score and comorbidity.
@en
Allogeneic hematopoietic cell ...... nt IPSS score and comorbidity.
@nl
type
label
Allogeneic hematopoietic cell ...... nt IPSS score and comorbidity.
@en
Allogeneic hematopoietic cell ...... nt IPSS score and comorbidity.
@nl
prefLabel
Allogeneic hematopoietic cell ...... nt IPSS score and comorbidity.
@en
Allogeneic hematopoietic cell ...... nt IPSS score and comorbidity.
@nl
P2093
P2860
P356
P1476
Allogeneic hematopoietic cell ...... nt IPSS score and comorbidity.
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2009.190
P407
P577
2009-08-10T00:00:00Z